Human NK cells and their receptors

Microbes and Infection

Volumn 4, Issue 15, 2002, Pages 1539-1544

  Moretta, Lorenzo ^a,b   Biassoni, Roberto ^c   Bottino, Cristina ^b   Cantoni, Claudia ^a,b   Pende, Daniela ^c   Mingari, Maria Cristina ^a,c   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute myeloid leukemias; Cytolytic T lymphocytes; Haploidentical bone marrow transplantation; HLA Cl I specific inhibitory receptors; HLA E; Killer Ig like receptors; NK cell alloreactivity; NK cells; NK like activity; Triggering NK receptors

Indexed keywords

CELL RECEPTOR; CELL RECEPTOR 2B4; CELL RECEPTOR KIR2DL1; CELL RECEPTOR KIR2DS1; CELL RECEPTOR KIR2DS2; CELL RECEPTOR LY49H; CELL RECEPTOR NKG2D; CELL RECEPTOR NTB A; HLA C ANTIGEN; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOWN REGULATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; MOLECULAR MECHANICS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANTIGENS, CD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0036927973     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00037-0     Document Type: Review

References (57)

1. Trincheri G. Biology of Natural Killer cells. Adv. Immunol. 47:1990;187-376.
2. Mingari M.C., Poggi A., Biassoni R., et al. In vitro proliferation and cloning of CD3-CD16+ cells from human thymocyte precursors. J. Exp. M. 174:1991;21-26.
3. Rodewald H.R., Moingeon P., Lucich J.L., Dosiou C., et al. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells. Cell. 69:1992;139-149.
4. Mingari M.C., Vitale C., Cantoni C., et al. Interleukin-15-induced maturation of human Natural Killer cells from early thymic precursors. Selective expression of CD94/NKG2A as the only HLA-class I specific inhibitory receptor. Eur. J. Immunol. 27:1997;1374-1380.
5. Miller J.S., McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 98:2001;705-711.
6. Sivori S., Falco M., Marcenaro E., et al. Early expression of triggering receptors and regulatory role of 2B4 in human NK cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA. 99:2002;4526-4531.
7. Cooper M.A., Fehninger T.A., Caligiuri M.A. The biology of human natural killer cell subsets. Trends Immunol. 22:2001;633-640.
8. Biron C.A., et al. Natural killer cells in antiviral defenses: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1999;189-220.
9. Ljunggren H.G., Karre K. In search of the "missing self". MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244.
10. Moretta L., Ciccone E., Moretta A., et al. Allorecognition by NK cells: nonself or no self? Immunol. Today. 13:1992;300-306.
11. Ciccone E., Viale O., Pende D., et al. Specific lysis of allogeneic cells after activation of CD3-lymphocytes in mixed lymphocyte culture. J. Exp. M. 168:1988;2403-2408.
12. Ciccone E., Pende D., Viale O., et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. M. 176:1992;963-971.
13. Colonna M., Borsellino G., Falco M., et al. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA. 90:1993;1200-1204.
14. Moretta A., Bottino C., Pende D., et al. Identification of four subset of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. M. 172:1990;1589-1598.
15. Moretta A., Vitale M., Bottino C., et al. P58 molecules as putative receptors for MHC class I molecules in human Natural Killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. M. 178:1993;597-604.
16. Moretta A., et al. Receptors for HLA-class I molecules in human Natural Killer cells. Annu. Rev. Immunol. 14:1996;619-648.
17. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:1999;875-904.
18. Lanier L.L. NK receptors. Annu. Rev. Immunol. 16:1998;359-393.
19. Lopez-Botet M., et al. Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules. Immunol. Rev. 155:1997;165-174.
20. Garrido F., et al. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumors. Immunol. Today. 18:1997;89-95.
21. Uhrberg M., Valiante N.M., Shum B.P., et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:1997;753-760.
22. Wilson M.J., Torkar M., Haude A., Milne T., Jones D., Beck Sheer S., Trowsdale J. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA. 97:2000;4778-4784.
23. Vilches C., Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20:2002;217-251.
24. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The Human Leukocyte Antigen (HLA)-C-specific "Activatory" or "Inhibitory" Natural Killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. M. 183:1996;645-650.
25. Bottino C., Sivori S., Vitale M., Cantoni C., Falco M., Pende D., Morelli L., Augugliaro R., Semenzato G., Biassoni R., Moretta L., Moretta A. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J. Immunol. 26:1996;1816-1824.
26. Trowsdale J., Barten R., Haude A., Andrew Stewart C., Beck S., Wilson M.J. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181:2001;20-38.
27. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27:1997;3095-3099.
28. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by Natural Killer cells. J. Immunol. 158:1997;5083-5086.
29. Lanier L.L., Corliss B.C., Jun W., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells. Nature. 391:1998;703-707.
30. Khakoo S.I., Rajalingam R., Shum B.P., Weidenbak K., Flodin L., Muir D.G., Canavez F., Cooper S.L., Valiante N.M., Lanier L.L., Parham P. Rapid evolution on NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity. 12:2000;687-698.
31. Moretta A., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:2001;197-223.
32. Moretta A., Biassoni R., Bottino C., et al. Natural Cytotoxicity Receptors that trigger human NK-mediated cytolysis. Immunol. Today. 21:2000;228-234.
33. Cerwenka A., Lanier L.L. Ligands for natural killer cell receptors: redundancy or specifity. Immunol. Rev. 181:2001;158-169.
34. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181:2001;170-184.
35. Sutherland C.L., Chalupny N.J., Cosman D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 181:2001;185-192.
36. Bonnet D., Warren E.H., Greenberg P.D., et al. CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci USA. 96:1999;8639-8644.
37. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L., Moretta A. B4 functions as a co-receptor in human Natural Killer cell activation. Eur. J. Immunol. 2:(30):2000;787-793.
38. Vitale M., Falco M., Castriconi R., Parolini S., Zambello R., Semenzato G., Biassoni R., Bottino C., Moretta L., Moretta A. Identification of NKp80, a novel triggering molecule expressed by human Natural Killer cells. Eur. J. Immunol. 31:2001;233-242.
39. Parolini S., Bottino C., Falco M., Augugliaro R., Giliani S., Franceschini R., Ochs H.D., Wolf H., Bonnefoy J.Y., Biassoni R., Moretta L., Notarangelo L.D., Moretta A. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of NK cell to kill EBV-infected cells. J. Exp. M. 192:2000;337-346.
40. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L.D., Moretta L., Moretta A. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. M. 194:2001;235-246.
41. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA. 95:1998;13765-13770.
42. Coffey A.J., Brooksbank R.A., Brandau O.O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P. Host response to EBV infction in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:1998;129-135.
43. Seemayer T.A., Gross T.G., Egeler R.M., Pirruccello S.J., Davis J.R., Kelly C.M., Okano M., Lanyi A., Sumegi J. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38:2001;471-478.
44. Mingari M.C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A.S., Moretta L. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA. 93:1996;12433-12438.
45. Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., Millo E., Anfossi S., Biassoni R., Moretta L., Mingari M.C. The analysis of the Natural Killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCRα/β-mediated recognition. Eur. J. Immunol. 2001;3687-3693.
46. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today. 21:2000;447-455.
47. Malnati M.S., Peruzzi M., Parker K.C., Biddison W.E., Ciccone E., Moretta A., Long E.O. Peptide specificity in the recognition of MHC class I by Natural Killer cells clones. Science. 267:1995;1016-1018.
48. Mandelboim O., Llieberman N., Lev M., Paul L., Arnoon T.L., Burshkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglotunins of virus-infected cells by NKp46 activated lysis by human NK cell. Nature. 409:2001;1055-1060.
49. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326.
50. Smith H.R.C., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., Scalzo A.A., Fremono D.H., Yokoyama W.M. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA. 10:2002;1073-1083.
51. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
52. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells recognized via the NKp30 receptors by activated NK cells. J. Exp. M. 195:2002;343-351.
53. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact -dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. M. 195:2002;335-341.
54. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trincheri G. Reciprocal activaying interaction between NK cells and dendritic cells. J. Exp. M. 195:2002;327-333.
55. Zitvogel L. Dendritic and Natural Killer Cells cooperate in the control/Switch of innate immunity. J. Exp. M. 195:2002;9-14.
56. Ruggeri L., Capanni M., Martelli M.F., Velardi A. Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr. Opin. Hematol. 6:2001;355-359.
57. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cells alloreactivity in mismatched hemapoietic transplants. Science. 295:2002;2097-2100.